vcyt: the income statement

MyFinsight

VERACYTE, INC. (VCYT)

For the quarter ending 2025-06-30, VCYT made $130,164K in revenue. -$980K in net income. Net profit margin of -0.75%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30	2025-03-31	2024-09-30	2024-06-30
Total revenue	130,164	114,473	115,860	114,428
Cost of revenue	-	32,380	33,933	33,606
Cost of revenue-Testing	32,407	-	-	-
Cost of revenue-Biopharmaceutical And Other	3,572	-	-	-
Cost of revenue-Product	1,749	-	-	-
Intangible asset amortization - cost of revenue	2,667	2,585	2,917	2,909
Total cost of revenue	40,395	34,965	36,850	36,515
Gross profit	89,769	79,508	79,010	77,913
Impairment of long-lived assets	-	-	185	-
Intangible asset amortization - operating expenses	-	622	880	881
Selling and marketing	25,316	24,454	22,612	24,216
Research and development	16,264	17,720	17,574	16,465
Intangible asset amortization - operating expenses-Intangible Asset Amortization	621	-	-	-
General and administrative	32,331	33,808	25,742	31,745
Impairment of assets	20,505	-	-	-
Total operating expenses	95,037	76,604	66,993	73,307
Income (loss) from operations	-5,268	2,904	12,017	4,606
Other income, net	6,518	4,524	4,831	2,755
Income (loss) before income taxes	1,250	7,428	16,848	7,361
Income tax provision	2,230	381	1,693	1,627
Net income (loss)	-980	7,047	15,155	5,734

Basic (in shares)	78,391,502	78,028,254	77,013,831	76,538,325
Basic (in usd per share)	-0.01	0.09	0.2	0.07
Diluted (in shares)	78,391,502	80,056,024	78,464,654	77,163,149
Diluted (in usd per share)	-0.01	0.09	0.19	0.07

Unit: Thousand (K) dollars (except for numbers of shares and EPS)